My book unveils the gripping journey of how I shaped the healthcare industry and faced an unprecedented battle against the United States justice system. I share my story of building and managing five publicly traded companies over a 48-year entrepreneurial career.

Discover the Secrets of Success

I recount the innovative management strategies that led to the successful public offerings of four different healthcare companies. This book is not just a professional autobiography; it's a blueprint for aspiring entrepreneurs, seasoned CEOs, and business professionals seeking to navigate the complex landscape of taking a company public in today’s new legal system. Myfirsthand insights provide invaluable lessons on leadership, growth, and resilience.

A Cautionary Tale of Legal Battles and Corporate Survival

The core of my narrative revolves around the tumultuous experience with my fifth company, MiMedx. As CEO, I faced aggressive short-seller attacks, false whistleblower accusations, and a devastating legal battle instigated by the Department of Justice. This book exposes the harsh realities of the "new justice system" that public companies must contend with, shedding light on the unscrupulous practices that can target top executives.

Essential Reading for Corporate Leaders

Designed as a guide for CEOs, CFOs, Board Members, Entrepreneurs and Shareholders, "The Entrepreneur's Dilemma" equips readers with the knowledge to protect their companies against unscrupulous legal tactics. My story of survival through the legal battles, brought on by the Sally Yates Doctrine, and my critique of the current legal landscape, offer a sobering look at the potential dangers awaiting public company executives.

Endorsements from Industry Giants

Endorsed by the President of the United States and other prominent CEOs, my story resonates with those who value integrity, perseverance, and conservative principles. My journey is a testament to the resilience required to withstand not just market challenges, but also the legal and political obstacles that can threaten a public company's very existence.